AXON Neuroscience Presented Results from its Phase II Clinical Trial Showing Multifold Therapeutic Effect of its Vaccine-Induced Antibodies at Eurotau2021
AXON presented results from its Phase II Clinical Study for AADvac1, vaccine against Alzheimer’s presented…
FY25 Results: Resilient Performance with Strong Profit Gains in Challenging Markets
ZIPAIR Launches Asia’s First Commercial Flight with Starlink Inflight Wi-Fi
Enablence Technologies Strengthens Leadership Team: Jianhua Hu Named Fab Director, Robert Piper Appointed Chief of Staff
Enablence Technologies Strengthens Leadership Team: Jianhua Hu Named Fab Director, Robert Piper Appointed Chief of Staff
Sigma Announces Development of 85mm F1.2 DG | Art Lens for Full-Frame Mirrorless Cameras